// App-Quantinova.ai

e15617 : Prognostic significance of the hepatoma arterial embolization prognostic (HAP) score in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization: A single centre experience.

Researchers

Presenter

  • Preetha Aravind

Principal Investigators

  • Kiruthikah Thillai

  • Debashis Sarker

  • Nigel Heaton

  • John Karani

  • Abid Suddle

  • Pauline Kane

  • Dylan Lewis

  • Praveen Peddu

  • Gillian Al-Kadhimi

  • Paul J. Ross

Medical Centers

  • Kings College London, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Department of Oncology, King's College Hospital, London, United Kingdom

  • Kings College London, London, United Kingdom

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • BCL2 Associated Athanogene 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final